The Ranbaxy family story contains two separate conflicts, not one continuous dispute: Bhai Mohan Singh and his son Parvinder fought over the company’s leadership and direction; years later, Parvinder’s sons Malvinder and Shivinder broke as business partners. The first changed who led Ranbaxy. The second played out across a wider group of businesses and through public allegations and legal proceedings.
How Bhai Mohan Singh and Parvinder Singh clashed over Ranbaxy
Business Standard’s historical account says Bhai Mohan Singh took over Ranbaxy after the company could not repay money he had lent it. He built a strong personal attachment to the business; according to the same report, he would tell friends, “Ranbaxy is my fourth child.” That is reported speech, not a quotation from a recording or primary document.
The conflict with Parvinder concerned Ranbaxy’s direction and executive leadership. Business Standard reports that Parvinder displaced his father from company leadership, expanded Ranbaxy internationally, and later passed leadership to D. S. Brar. Parvinder died in 2000. His son Malvinder subsequently rose through the company and, according to the report, was in control by December 2003.
This account establishes a succession struggle over leadership and strategy. It does not, by itself, establish that the father and son were engaged in a single, formally defined ownership lawsuit.
Recommended Free Tools
#1 Best Overall
- Author: Walton, Sam.
- Publisher: Bantam
- Pages: 368
- Publication Date: 1993
- Edition: Illustrated
How Malvinder and Shivinder’s partnership broke down
Parvinder’s sons Malvinder and Shivinder were associated with Ranbaxy as well as Fortis Healthcare and Religare Enterprises. Their later conflict therefore concerned business relationships beyond the original Ranbaxy leadership handover.
A contemporaneous 2018 news report said Shivinder had filed a suit alleging oppression and mismanagement against Malvinder and a senior manager. Those were the complainant’s allegations, not findings by a court. The report said Shivinder withdrew the suit after their mother asked the brothers to pursue family mediation. It also reported that Shivinder’s decision to disassociate from Malvinder as a business partner remained despite the withdrawal.
The same 2018 account described a broader collapse affecting the family’s healthcare and financial-services businesses and referred to a court order concerning allegations connected with the 2008 sale of Ranbaxy. Those descriptions belong to that report’s time and framing; they should not be read as a current financial snapshot or as a definitive account of the present status of every dispute.
How the two conflicts differ
| Conflict | Business issue described in the sources | Evidence and limits |
|---|---|---|
| Bhai Mohan Singh and Parvinder Singh | Ranbaxy’s leadership and direction | Business Standard’s historical account; it does not establish a single ownership lawsuit. |
| Malvinder and Shivinder Singh | Business partnership and governance across businesses including Ranbaxy, Fortis Healthcare, and Religare Enterprises | A 2018 news report describes a withdrawn suit and the brothers’ positions; allegations are not court findings. |
The distinction matters: the father–son clash was reported as a struggle over who would lead Ranbaxy and how it would develop, while the brothers’ rupture involved a wider set of business interests and later legal allegations. Treating them as one dispute obscures both the different relationships and the different kinds of evidence.
Quick wins for a faster PC:
Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →What the later court records establish—and what they do not
A Delhi High Court order dated 21 February 2022 recounts the background to bail proceedings involving Malvinder and Shivinder. In that background, complainant companies alleged that the brothers had controlled Religare Enterprises and subsidiaries until they left board positions in February 2018. These are allegations recited in a procedural bail order; that order’s background is not a finding of guilt.
A tax tribunal decision dated 29 January 2025 reproduces details of a confidential family arrangement dated 26 August 2007. It describes an understanding for the transfer or sale of 30 lakh Ranbaxy shares from Shivinder to Malvinder or his companies, with payment deferred. This documents a particular share arrangement between the brothers. It does not establish that they had settled all later business disagreements.
The available record described here does not establish the complete status, as of 8 October 2026, of every lawsuit or family-trust dispute associated with the brothers. No present-day conclusion that all such matters remain pending, have ended, or have been resolved follows from the dated reports and decisions above.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Why this is a business succession story as well as a family story
For readers interested in family-controlled companies, the Ranbaxy history illustrates why leadership succession, share arrangements, and broader business partnerships should be distinguished. A change in who runs a company does not necessarily answer who owns shares; a documented transfer arrangement does not necessarily settle every disagreement among relatives; and allegations appearing in a court record are not equivalent to a judicial finding.
Best Value
- From the acclaimed, award-winning author of Alexander Hamilton: here is the essential, endlessly engrossing biography of John D. Rockefeller, Sr.—the Jekyll-and-Hyde of American capitalism.
- In the course of his nearly 98 years, Rockefeller was known as both a rapacious robber baron, whose Standard Oil Company rode roughshod over an industry, and a philanthropist who donated money lavishly to universities and medical centers.
- He was the terror of his competitors, the bogeyman of reformers, the delight of caricaturists—and an utter enigma.
Here, the central historical thread is a transfer of leadership from Bhai Mohan Singh’s generation to Parvinder’s, followed by a later rupture between Parvinder’s sons across several businesses. The sources support that sequence, but they do not justify collapsing the two conflicts into a single cause or claiming a definitive current legal outcome.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
